中文 | English
Autoimmune hepatitis (AIH) is a chronic condition in which the body's immune system mistakenly attacks liver cells, causing inflammation and liver damage. Unlike viral hepatitis, AIH is not caused by an infection but rather by an abnormal immune response. Without treatment, AIH can progress to cirrhosis, liver failure, and the need for liver transplantation.
AIH can affect people of all ages, ethnicities, and genders, though it is more common in women (approximately 70% of cases). There are two main types: Type 1 (most common, occurs at any age) and Type 2 (primarily affects children and young adults). The condition may present acutely with jaundice and severe symptoms, or develop gradually with vague complaints like fatigue.
At Dr. Jing Tong Gastroenterology in Flushing, we provide comprehensive evaluation and long-term management of autoimmune hepatitis. With proper immunosuppressive therapy, most patients achieve remission and maintain good quality of life. Early diagnosis and treatment are essential to prevent irreversible liver damage.
Advanced fellowship training with expertise in complex autoimmune liver conditions and immunosuppressive management.
Licensed in therapeutic endoscopy for comprehensive evaluation when AIH complications arise.
Clear communication in English, Mandarin, and Cantonese about complex autoimmune conditions and treatment plans.
AIH requires lifelong monitoring. We provide consistent, personalized follow-up care to maintain remission.
No. Unlike viral hepatitis, autoimmune hepatitis is NOT contagious. It is caused by your own immune system attacking your liver cells. You cannot spread it to others through any form of contact.
Most patients require long-term immunosuppressive therapy. Some patients can eventually taper off medication after achieving sustained remission, but relapse rates are high (up to 80%). Each case is individual, and Dr. Tong will discuss the best approach for your situation.
Corticosteroids can cause weight gain, diabetes, osteoporosis, and mood changes. Azathioprine may cause nausea and increased infection risk. We carefully monitor for side effects and adjust treatment to minimize them while maintaining remission.
If AIH progresses to cirrhosis, there is an increased risk of hepatocellular carcinoma (liver cancer). This is why regular monitoring and maintaining remission are so important. Patients with cirrhosis from AIH undergo cancer surveillance every 6 months.
Yes. AIH often coexists with other autoimmune conditions such as thyroid disease, rheumatoid arthritis, ulcerative colitis, celiac disease, and type 1 diabetes. A comprehensive evaluation can identify overlapping conditions.
Get a proper diagnosis and personalized treatment plan. Call Dr. Jing Tong today.
